HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Efficacy of chemotherapy for clear cell adenocarcinoma of the ovary].

Abstract
In line with various protocols for chemotherapy of ovarian carcinoma, we used EP (etoposide-cisplatin or carboplatin) therapy in 10 patients with clear cell adenocarcinoma as the first line chemotherapy. Four of these cases were in advanced stage at IIIc, and had residual tumor after the operation. One of these patients with measurable tumor responded to semi-high dose treatment, and 5-days of continuous infusion of etoposide resulted in CR. Three cases of a patient at the stages of Ic and IIc are in disease free status after two years of standard-dose EP therapy. Therefore, high-dose EP therapy might be an effective chemotherapy for some patients with ovarian clear cell adenocarcinoma.
AuthorsT Okubo, S Takeda, K Ikeba, Y Takagi, O Ishihara, H Seki, K Kinoshita
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 24 Issue 10 Pg. 1279-83 (Aug 1997) ISSN: 0385-0684 [Print] Japan
PMID9279347 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Etoposide
  • Carboplatin
  • Cisplatin
Topics
  • Adenocarcinoma, Clear Cell (drug therapy, surgery)
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carboplatin (administration & dosage)
  • Cisplatin (administration & dosage)
  • Disease-Free Survival
  • Drug Administration Schedule
  • Etoposide (administration & dosage)
  • Female
  • Humans
  • Hysterectomy
  • Lymph Node Excision
  • Middle Aged
  • Ovarian Neoplasms (drug therapy, surgery)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: